Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care
Clinical trial NCT06660719 · RECRUITING
Trial details
- NCT number
- NCT06660719
- Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-14
- Primary completion
- 2027-03-30
- Enrollment
- 852
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.